Trial Of COVID-19 Vaccination Begins In Africa

Africa’s first participation in a COVID-19 vaccine trial started Wednesday in South Africa as nervous volunteers received injections, while officials said the continent of 1.3 billion people cannot be left behind.

The large-scale trial of the vaccine developed at the University of Oxford in Britain is being conducted in South Africa, Britain and Brazil. South Africa has nearly one-third of Africa’s confirmed cases with more than 106,000, including more than 2,100 deaths. The country late Tuesday reported its biggest one-day death toll of 111.

LEAVE A REPLY

Please enter your comment!
Please enter your name here